Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00272337 · ClinicalTrials.gov registry record · Phase 4
Aspirin Dose and Atherosclerosis in Patients With Heart Disease
A Phase 4 study, sponsored by Florida Atlantic University.
- Completed
- Registry status
- Phase 4
- Development phase
- 37
- Enrollment target
NCT00272337 is a Phase 4 study that has completed, run by Florida Atlantic University. The registered enrollment target is 37 participants.
The verdict
NCT00272337, a Phase 4 study, has completed, sponsored by Florida Atlantic University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of the study is to test higher versus lower doses of aspirin on markers of atherosclerosis in patients who have had a heart attack.
Interventions
- DRUG Aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00272337
The ClinicalTrials.gov registry entry for NCT00272337 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida Atlantic University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aspirin is the first listed.
NCT00272337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00272337 about?
NCT00272337 is a clinical study titled "Aspirin Dose and Atherosclerosis in Patients With Heart Disease". The purpose of the study is to test higher versus lower doses of aspirin on markers of atherosclerosis in patients who have had a heart attack.
What is the current status of trial NCT00272337?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 2006-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00272337?
The interventions under investigation include: Aspirin (DRUG).
Who is sponsoring clinical trial NCT00272337?
This trial is sponsored by Florida Atlantic University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.